-
Signature
-
/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening
-
Stock symbol
-
(CALX)
-
Transactions as of
-
Jun 2, 2025
-
Transactions value $
-
-$4,029,310
-
Form type
-
4
-
Date filed
-
6/3/2025, 04:25 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Weening Michael |
President & CEO, Director |
C/O CALIX, INC., 2777 ORCHARD PARKWAY, SAN JOSE |
/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening |
2025-06-03 |
0001678385 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$510K |
+80K |
+505.94% |
$6.38 |
95.8K |
Jun 2, 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$119K |
+20K |
+20.87% |
$5.95 |
116K |
Jun 2, 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Sale |
-$4.66M |
-100K |
-86.35% |
$46.59 |
15.8K |
Jun 2, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-80K |
-100% |
$0.00 |
0 |
Jun 2, 2025 |
Common Stock |
80K |
$6.38 |
Direct |
F2 |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-20K |
-9.8% |
$0.00 |
184K |
Jun 2, 2025 |
Common Stock |
20K |
$5.95 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
Sales reported on the Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan.